The increasing demand for plasma protein therapeutics for treatment of autoimmune neurologic diseases, acute cardiomyopathy, multifocal motor neuropathy (MMN), hemolytic disease of the newborn, autoimmune mucocutaneous blistering diseases, and acute panautonomic polyneuropathy is the prime factor towards the growth of the global plasma protein therapeutics market.
North America is the principal contributor to the global Plasma Protein Therapeutics market.
Based on type, the Plasma Protein Therapeutics market is segmented intoimmunoglobulin, albumin, plasma derived factor VIII, and others..
Key Plasma Protein Therapeutics market players are Baxter International Inc., Biotest Pharmaceuticals Corporation, China Biologic Products, Inc., CSL Behring, GRIFOLS, S.A, Kedrion S.p.A., Octapharma USA, Inc., Shire Plc. and others.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved